Clinical Trial Update: Transcranial Direct Current Stimulation Plus Monoclonal Antibodies Acting on the CGRP Pathway for Migraine [NA]

View source ↗

Summary

Clinical trial update reporting the completion of a study combining transcranial direct current stimulation with CGRP-pathway monoclonal antibodies for migraine…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• CGRP pathway monoclonal antibodies (unspecified)

Snippet

Sponsor: University of L'Aquila | Conditions: Migraine | NA | Status: COMPLETED